BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11408034)

  • 1. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
    Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
    Di Marzo V; Breivogel C; Bisogno T; Melck D; Patrick G; Tao Q; Szallasi A; Razdan RK; Martin BR
    Eur J Pharmacol; 2000 Oct; 406(3):363-74. PubMed ID: 11040343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V; Griffin G; De Petrocellis L; Brandi I; Bisogno T; Williams W; Grier MC; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):984-91. PubMed ID: 11861807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
    de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
    Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
    FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
    Malinowska B; Kwolek G; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
    J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).
    McVey DC; Schmid PC; Schmid HH; Vigna SR
    J Pharmacol Exp Ther; 2003 Feb; 304(2):713-22. PubMed ID: 12538826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
    Brooks JW; Pryce G; Bisogno T; Jaggar SI; Hankey DJ; Brown P; Bridges D; Ledent C; Bifulco M; Rice AS; Di Marzo V; Baker D
    Eur J Pharmacol; 2002 Mar; 439(1-3):83-92. PubMed ID: 11937096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.
    Sprague J; Harrison C; Rowbotham DJ; Smart D; Lambert DG
    Eur J Pharmacol; 2001 Jul; 423(2-3):121-5. PubMed ID: 11448475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
    Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
    Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D
    Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J; Urban L; Bevan S; Nagy I
    Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
    del Carmen García M; Adler-Graschinsky E; Celuch SM
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
    Lastres-Becker I; de Miguel R; De Petrocellis L; Makriyannis A; Di Marzo V; Fernández-Ruiz J
    J Neurochem; 2003 Mar; 84(5):1097-109. PubMed ID: 12603833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response.
    Hermann H; De Petrocellis L; Bisogno T; Schiano Moriello A; Lutz B; Di Marzo V
    Cell Mol Life Sci; 2003 Mar; 60(3):607-16. PubMed ID: 12737320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.